We are live on
!
Find out more
BCM
Buckhead Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
11.84%
This Fund
S&P 500
This Quarter
Est. Return
-4.5%
1 Year Est. Return
+11.84%
3 Year Est. Return
+54.43%
5 Year Est. Return
+77.71%
10 Year Est. Return
+247.44%
AUM
$386M
AUM Growth
-$17.7M
(-4.4%)
Cap. Flow
+$2.47M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
29.15%
Holding
129
New
3
Increased
41
Reduced
53
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$8.92M |
| 2 |
Altria Group
MO
|
+$2.18M |
| 3 |
Air Products & Chemicals
APD
|
+$1.99M |
| 4 |
Casey's General Stores
CASY
|
+$1.4M |
| 5 |
Charles River Laboratories
CRL
|
+$1.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$7.41M |
| 2 |
J&J Snack Foods
JJSF
|
+$2.34M |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.17M |
| 4 |
CF Industries
CF
|
+$1.15M |
| 5 |
Apple
AAPL
|
+$941K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Healthcare | 15.97% |
| 3 | Financials | 13.74% |
| 4 | Consumer Staples | 11.46% |
| 5 | Consumer Discretionary | 9.52% |
Similar funds
WFG
AFA
WRTC
LWMI
DWA
BIA
SEM
NI
Buckhead Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Buckhead Capital Management held 129 positions worth $386M, down 4.4% from $404M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Buckhead Capital Management's Q3 2022 filing shows 3 new, 41 increased, 53 reduced and 6 closed positions. Its largest new stake was GSK: 235,278 shares worth $6.92M. The largest sale was Novartis, an estimated $7.41M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- Buckhead Capital Management's largest Q3 2022 buy was GSK: 235,278 shares worth $6.92M.
- Buckhead Capital Management added most to Air Products & Chemicals in Q3 2022, an estimated $1.99M increase.
- Buckhead Capital Management's biggest Q3 2022 reduction was J&J Snack Foods, cutting an estimated $2.34M.
- Buckhead Capital Management fully exited Novartis in Q3 2022, selling an estimated $7.41M.
- Buckhead Capital Management's ten largest holdings make up 29% of its $386M portfolio in Q3 2022.
- Buckhead Capital Management opened 3 new positions and closed 6 in Q3 2022.
- Buckhead Capital Management's portfolio value fell 4.4% quarter-over-quarter to $386M.
Based on Buckhead Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.